CA2190344A1 - Quillaja saponin adjuvant and vaccine formulation containing same - Google Patents

Quillaja saponin adjuvant and vaccine formulation containing same

Info

Publication number
CA2190344A1
CA2190344A1 CA002190344A CA2190344A CA2190344A1 CA 2190344 A1 CA2190344 A1 CA 2190344A1 CA 002190344 A CA002190344 A CA 002190344A CA 2190344 A CA2190344 A CA 2190344A CA 2190344 A1 CA2190344 A1 CA 2190344A1
Authority
CA
Canada
Prior art keywords
vaccine formulation
formulation containing
containing same
adjuvant
saponin adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002190344A
Other languages
French (fr)
Other versions
CA2190344C (en
Inventor
Hye Sung Yoon
Young Sun Kwon
Joong Myung Cho
Hong Seob So
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Corp
Original Assignee
Hye Sung Yoon
Young Sun Kwon
Joong Myung Cho
Hong Seob So
Lg Chemical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hye Sung Yoon, Young Sun Kwon, Joong Myung Cho, Hong Seob So, Lg Chemical Ltd. filed Critical Hye Sung Yoon
Publication of CA2190344A1 publication Critical patent/CA2190344A1/en
Application granted granted Critical
Publication of CA2190344C publication Critical patent/CA2190344C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Abstract

A novel saponin component having a molecular weight of about 956 daltons, a process for isolating the saponin component from the bark of Quillaja saponaria Molina, a vaccine formulation comprising the saponin component as an immune adjuvant, a method for increasing the immune response to an antigen by employing an adjuvant composition comprising saponin component and a second adjuvant.
CA002190344A 1995-04-13 1996-04-12 Quillaja saponin adjuvant and vaccine formulation containing same Expired - Fee Related CA2190344C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19950008589 1995-04-13
KR1995/8589 1995-04-13
KR19950008590 1995-04-13
KR1995/8590 1995-04-13
PCT/KR1996/000053 WO1996032401A1 (en) 1995-04-13 1996-04-12 Quillaja saponin adjuvant and vaccine formulation containing same

Publications (2)

Publication Number Publication Date
CA2190344A1 true CA2190344A1 (en) 1996-10-16
CA2190344C CA2190344C (en) 2001-04-10

Family

ID=37027969

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002190344A Expired - Fee Related CA2190344C (en) 1995-04-13 1996-04-12 Quillaja saponin adjuvant and vaccine formulation containing same

Country Status (16)

Country Link
US (1) US5817314A (en)
EP (1) EP0765333B1 (en)
JP (1) JP2761809B2 (en)
KR (1) KR0184779B1 (en)
CN (2) CN1044478C (en)
AR (1) AR001618A1 (en)
AT (1) ATE186541T1 (en)
AU (1) AU678941B2 (en)
BR (1) BR9606311A (en)
CA (1) CA2190344C (en)
DE (1) DE69605094T2 (en)
DK (1) DK0765333T3 (en)
ES (1) ES2140837T3 (en)
MX (1) MX9601378A (en)
TW (1) TW442293B (en)
WO (1) WO1996032401A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
WO1999010008A1 (en) * 1997-08-29 1999-03-04 Aquila Biopharmaceuticals, Inc. Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
US6262029B1 (en) 1998-08-14 2001-07-17 Galenica Pharmaceuticals, Inc. Chemically modified saponins and the use thereof as adjuvants
TW586935B (en) * 1998-09-14 2004-05-11 Kitasato Inst Saponin-containing vaccine preparation
KR100629028B1 (en) * 1998-10-16 2006-09-26 글락소스미스클라인 바이오로지칼즈 에스.에이. Adjuvant systems and vaccines
EP1235591A1 (en) * 1999-12-08 2002-09-04 Statens Veterinärmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminium salt
US6905712B2 (en) * 1999-12-08 2005-06-14 Statens Veterinarmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminum salt
US8883170B2 (en) * 2008-09-03 2014-11-11 Western Illinois University Research Foundation Adjuvant
EP2359702B1 (en) 2010-01-22 2014-06-04 Symrise AG Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
EP2359698B1 (en) 2010-01-22 2013-12-04 Symrise AG Compositions with a surfactant system comprising saponins, and lecithin
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
CN103347529B (en) 2010-12-09 2016-10-26 Y&B妈妈之选有限公司 Preparation comprising saponin and application thereof
EP2648809B1 (en) 2010-12-09 2019-04-03 Y&B Mother's Choice Ltd. Natural formulations
EP2628398B1 (en) 2012-02-19 2016-09-07 Symrise AG Compositions of matter
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Preparations for suppressing or attenuating ocular irritancy
CN105213471A (en) * 2014-05-29 2016-01-06 江口县苗药生物科技有限公司 A kind of extraction process of soapbark total saponins
CN111372604A (en) * 2017-12-01 2020-07-03 葛兰素史密丝克莱恩生物有限公司 Extraction of saponins
WO2019106192A1 (en) 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin purification
TWI820099B (en) * 2018-03-28 2023-11-01 台灣浩鼎生技股份有限公司 Novel saponin adjuvant and evaluation method thereof
CN116355035B (en) * 2021-12-28 2024-03-12 成都迈科康生物科技有限公司 Preparation method of QS21 immunoadjuvant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
ES2199227T5 (en) * 1993-03-29 2007-12-01 Pfizer Inc. MULTICOMPONENT CLOSTRIDIAL VACCINES USING SAPONINA ASSISTANTS.

Also Published As

Publication number Publication date
KR960037694A (en) 1996-11-19
AU678941B2 (en) 1997-06-12
AR001618A1 (en) 1997-11-26
MX9601378A (en) 1997-04-30
CA2190344C (en) 2001-04-10
DE69605094D1 (en) 1999-12-16
KR0184779B1 (en) 1999-04-01
EP0765333B1 (en) 1999-11-10
AU5290096A (en) 1996-10-30
JPH09510740A (en) 1997-10-28
CN1149875A (en) 1997-05-14
TW442293B (en) 2001-06-23
BR9606311A (en) 1997-09-16
ATE186541T1 (en) 1999-11-15
EP0765333A1 (en) 1997-04-02
DE69605094T2 (en) 2000-07-06
ES2140837T3 (en) 2000-03-01
DK0765333T3 (en) 2000-03-13
WO1996032401A1 (en) 1996-10-17
JP2761809B2 (en) 1998-06-04
CN1044478C (en) 1999-08-04
US5817314A (en) 1998-10-06
CN1262958A (en) 2000-08-16

Similar Documents

Publication Publication Date Title
CA2190344A1 (en) Quillaja saponin adjuvant and vaccine formulation containing same
CA2217178A1 (en) Vaccines containing a saponin and a sterol
EP1170016A3 (en) Urease-based vaccine against helicobacter infection
AU1934088A (en) Saponin adjuvant
CA2237529A1 (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
WO1997001640A3 (en) Vaccines against hepatitis c
NZ293882A (en) Preparation comprising saponins of quillaja saponaria, immunostimulatory complexes and vaccines
NZ512011A (en) Improved saponin adjuvant compositions and methods relating thereto
AU5072890A (en) Fungal formulation for biocontrol of soilborne plant pathogens
PL340659A1 (en) Spheroides, method of obtaining them and pharmacological compositions
AU4195897A (en) Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
CA2393072A1 (en) Mono- and disaccharide derivatives
AU4622693A (en) Potentiation of immunogenic response
CA2077434A1 (en) Antigenic proteins of borrelia burgdorferi
CA2154063A1 (en) Treatment of h. pylori associated gastroduodenal disease
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
JPS5782322A (en) Novel immunostimulant sugar protein extracted from pneumonia bacillus,obtaining method, application as drug and composition containing same
NZ295238A (en) Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase
WO1997018222A3 (en) Novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties
CA2182274A1 (en) Antigenic preparation for treatment or prevention of helicobacter infection
AU8147094A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
EP0757556A4 (en) -i(BORRELIA BURGDORFERI) BACTERIN
JPS5782321A (en) Novel water-soluble immunostimulant sugar protein extracted from pneumonia bacillus, obtaining method,application as drug and composition containing same
CA2355466A1 (en) Multi-component vaccine comprising at least two antigens from haemophilus influenzae
AU6511890A (en) Method for the preparation of an immunizing composition

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed